Bellerophon Therapeutics
BLPH
Rank 5559
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 184 LIBERTY CORNER ROAD, SUITE 302, WARREN, NJ, US
Bellerophon Therapeutics - Key figures
Market cap 8.78 Million
Revenue No information
Profit No information
P/E Ratio No information
P/s Ratio -
Bellerophon Therapeutics - Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutic company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States.
The company is headquartered in Warren, New Jersey.